Volume 20 Number 13

EuroIntervention’s Impact Factor is now 7.6! And in this issue of the Journal we bring you an Expert Review on stroke in TAVI; a viewpoint on drug-coated balloons for acute coronary syndromes; biolimus- vs paclitaxel-coated balloons, from the BIO ASCEND ISR study; target lesion failure after drug-coated balloon PCI; paclitaxel-coated balloons for vulnerable lipid-rich plaques; the EASTBOURNE Registry’s 2-year outcomes of sirolimus-coated balloon angioplasty for coronary artery disease; a Flashlight on a first-in-human case of transcatheter mitral valve replacement in a dysfunctional valve; news from the EAPCI; and more...

Snapshot

Stroke in TAVI; biolimus- vs paclitaxel-coated balloons; target lesion failure after drug-coated balloon PCI; paclitaxel-coated balloons for vulnerable lipid-rich plaques; sirolimus-coated balloon angioplasty for coronary artery disease; and more

free

Viewpoint

Drug-coated balloons for acute coronary syndromes

Scheller B, Eccleshall S

10.4244/EIJ-E-24-00019

free

Expert Review

Cerebrovascular events after transcatheter aortic valve implantation

Reddy P, Merdler I, Ben-Dor I, Satler LF, Rogers T, Waksman R

10.4244/EIJ-D-23-01087

free

Original Research

Biolimus-coated versus paclitaxel-coated balloons for coronary in-stent restenosis (BIO ASCEND ISR): a randomised, non-inferiority trial

Chen Y, Gao L, Qin Q, Zhang J, Jia S, Wu M, He Y, Fu G, Liu J, Chen H, Tong Q, Yu Z, An J, Qiu C, Xu B, Cao Y, Wang C, Ma G

10.4244/EIJ-D-24-00295

Editorial comment

Angioplasty with drug-coated balloon catheters: the coming tide?

Byrne R, Durand R

10.4244/EIJ-E-24-00035

free

Predictors of target lesion failure after percutaneous coronary intervention with a drug-coated balloon for de novo lesions

Lee T, Ashikaga T, Nozato T, Nagata Y, Kaneko M, Miyazaki R, Misawa T, Taomoto Y, Okata S, Nagase M, Horie T, Terui M, Kachi D, Odanaka Y, Matsuda K, Naito M, Koido A, Yonetsu T, Sasano T

10.4244/EIJ-D-23-01006

Editorial comment

Aggressive predilatation seeking medial dissection: a prerequisite for a drug-coated balloon-only strategy in de novo coronary lesions?

Adriaenssens T, Bennett J

10.4244/EIJ-E-24-00036

free

Research Correspondence

Paclitaxel-coated balloons for vulnerable lipid-rich plaques

van Veelen A, Küçük IT, García-García HM, Fuentes FH, Kahsay Y, Delewi R, Beijk MA, den Hartog AW, Grundeken MJ, Vis MM, Henriques JP, Claessen B

10.4244/EIJ-D-23-01073

Two-year outcomes of sirolimus-coated balloon angioplasty for coronary artery disease: the EASTBOURNE Registry

Leone PP, Heang TM, Yan LC, Perez IS, Caiazzo G, Geraci S, Jiyen K, Tomai F, Buccheri D, Seresini G, Singh R, Karavolias G, Cacucci M, Ocaranza R, Torres A, Caruso M, Azzalini L, Pesenti N, Colombo A, Cortese B, investigators obotE

10.4244/EIJ-D-23-00966

Flashlight

First-in-human implantation of a customised balloon-expandable valve into a dysfunctional Tendyne valve

Denti P, Saccocci M, Buzzatti N, Zancanaro E, Maisano F

10.4244/EIJ-D-23-01034

EAPCI Column

EAPCI General Assembly 2024

free